side effects of stopping tirzepatide cold turkey What Really Happens When You Stop GLP‑1 In 2026? A One‑Day Story Your Scale Can't Tell You The Hidden Risks of Going

Responding to the study's findings, Professor Tim Chico, an expert in cardiovascular medicine at the University of Sheffield who wasn't involved in the research, said: 'It suggests the benefits of the drug are not only caused by causing weight loss

Bliddal, H., Leeds, A

Given the rapid increase in semaglutide use and its possible licensing for a range of problems other than obesity and T2DM, this issue deserves further study, but possible drug side effects always need to be balanced against likely benefits, he added

Cardiovascular outcome trials evaluating novel agents that target multiple pathways, including combinations of GLP-1 agonism, GIP agonism, glucagon receptor agonism and amylin analogues, are eagerly awaited